{
  "summary": "Rani Therapeutics announced positive results from Phase 2 clinical trial of RT-109 for diabetes treatment. The oral insulin delivery platform showed promising efficacy and safety profile.",
  "generated_at": "2025-07-26T21:54:24.741210",
  "filing_form": "8-K",
  "filing_date": "2024-04-08"
}